PRC1 and cervical squamous intraepithelial neoplasia: We performed RNA-sequencing on low-risk 92.1 cells with and without CIN induction through reversine treatment, a potent inhibitor of the mitotic kinase Mps162 in the absence of PRC1 inhibition.